Organovo

About Organovo

Organovo Holdings Inc is a biotechnology company specializing in the development of 3D human tissues for research and medical applications. Using its proprietary NovoGen Bioprinters, Organovo creates living tissues that mimic key aspects of human disease, supporting drug discovery and disease modeling. The company’s technology enables the fabrication of multicellular tissues with complex architecture, and its pipeline includes candidates for inflammatory bowel disease and liver fibrosis. Organovo collaborates with leading research institutions to advance its bioprinting platform.